Delayed Melanoma Care During Pandemic Proved Costly

TUESDAY, Feb. 27, 2024 -- Delays in melanoma diagnoses due to COVID-19 pandemic lockdowns were associated with a significant burden, including years of life lost and costs, according to a study published online Feb. 16 in JAMA Network...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news